About N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide
N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide (PubChem CID 118135937) has the molecular formula C23H23ClN4O4
and a molecular weight of 454.91 g/mol. Its IUPAC name is N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide |
| PubChem CID | 118135937 |
| Molecular Formula | C23H23ClN4O4 |
| Molecular Weight | 454.91 g/mol |
| Exact Mass | 454.14 |
| IUPAC Name | N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide |
| SMILES | Cc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)N3CC(C)(O)C3)c2n1 |
| InChI | InChI=1S/C23H23ClN4O4/c1-14-3-6-16-9-18(21(30)25-10-15-4-7-17(24)8-5-15)22(31)28(20(16)26-14)11-19(29)27-12-23(2,32)13-27/h3-9,32H,10-13H2,1-2H3,(H,25,30) |
| InChIKey | WMXZTUNXSQRENU-UHFFFAOYSA-N |
| XLogP | 1.88 |
| TPSA | 104.53 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 454.91 |
| LogP ≤ 5 | 1.88 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Analyze N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide?
The IUPAC name of N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide (CID 118135937) is N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide.
What is the SMILES notation for N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide?
The canonical SMILES for N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide is Cc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)N3CC(C)(O)C3)c2n1.
What is the InChIKey of N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide?
The InChIKey is WMXZTUNXSQRENU-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H23ClN4O4/c1-14-3-6-16-9-18(21(30)25-10-15-4-7-17(24)8-5-15)22(31)28(20(16)26-14)11-19(29)27-12-23(2,32)13-27/h3-9,32H,10-13H2,1-2H3,(H,25,30).
What are the key properties of N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide?
N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide has a molecular weight of 454.91 g/mol, XLogP of 1.88, 5 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-methyl-2-oxo-1,8-naphthyridine-3-carboxamide is sourced from PubChem (CID 118135937), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).